References

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

10.1016/s0140-6736(12)61729-2 · 2012 · External reference

Schistosomiasis

10.1038/nrmicro801 · 2004 · External reference

Unresolved reference

2022 · External reference

Schistosomiasis mansoni -- clinical features

10.1157/13070382 · 2005 · External reference

The effect of the number of stool samples on the observed prevalence and the infection intensity with Schistosoma mansoni among a population in an area of low transmission

10.1016/j.actatropica.2008.09.016 · 2008 · External reference

A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni

10.4269/ajtmh.12-0639 · 2013 · External reference

Translating From Egg- to Antigen-Based Indicators for Schistosoma mansoni Elimination Targets: A Bayesian Latent Class Analysis Study

10.3389/fitd.2022.825721 · 2022 · External reference

Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi

10.1186/s13071-018-2700-4 · 2018 · External reference

Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda

10.1186/s13071-017-2580-z · 2018 · External reference

Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses

10.3389/fimmu.2018.03042 · 2018 · External reference

Katayama fever: an acute manifestation of schistosomiasis

10.1136/bmj.313.7064.1071 · 1996 · External reference

Studies on Granuloma Formation

10.4049/jimmunol.95.5.959 · 1965 · External reference

Endoscopic findings and clinicopathologic characteristics of colonic schistosomiasis: a report of 46 cases

10.3748/wjg.v16.i6.723 · 2010 · External reference

Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe

10.1016/j.trstmh.2008.03.010 · 2008 · External reference

Chronic Schistosomiasis in a Patient with Rectal Cancer

10.4269/ajtmh.2009.80.1 · 2009 · External reference

Schistosomiasis: Still a Cause of Significant Morbidity and Mortality

2019 · External reference

Praziquantel

10.1002/med.2610030204 · 1983 · External reference

Unresolved reference

2020 · External reference

Human schistosomiasis

10.1016/s0140-6736(13)61949-2 · 2014 · External reference

Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis

10.1097/qco.0b013e328318978f · 2008 · External reference

Praziquantel

10.1007/s00436-002-0751-z · 2003 · External reference

Susceptibility or resistance of praziquantel in human schistosomiasis: a review

10.1007/s00436-012-3151-z · 2012 · External reference

Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance

10.1128/aac.02582-16 · 2017 · External reference

Human schistosomiasis resistance to praziquantel in China: should we be worried?

10.4269/ajtmh.2011.10-0542 · 2011 · External reference

Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy

10.1371/journal.pntd.0009189 · 2021 · External reference

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration

10.1093/cid/ciw506 · 2016 · External reference

Reconciling Egg- and Antigen-Based Estimates of Schistosoma mansoni Clearance and Reinfection: A Modeling Study

10.1093/cid/ciab679 · 2022 · External reference

Prevention and control of schistosomiasis: a current perspective

2014 · External reference

Praziquantel, a new board-spectrum antischistosomal agent

10.1007/bf00389899 · 1977 · External reference

Are Ca2+ channels targets of praziquantel action?

10.1016/j.ijpara.2004.09.004 · 2005 · External reference

Praziquantel activates a native cation current in Schistosoma mansoni

10.3389/fpara.2023.1285177 · 2023 · External reference

Impacts of host gender on Schistosoma mansoni risk in rural Uganda-A mixed-methods approach

2020 · External reference

Praziquantel

10.1007/s00436-002-0751-z · 2003 · External reference

Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia

10.1016/s0001-706x(98)00084-9 · 1999 · External reference

Praziquantel side effects during treatment of Schistosoma mansoni infected pupils in Kibwezi, Kenya

1996 · External reference

Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d’Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST)

10.1371/journal.pntd.0008189 · 2020 · External reference

Systematic review of community-based, school-based, and combined delivery modes for reaching school-aged children in mass drug administration programs for schistosomiasis

10.1371/journal.pntd.0006043 · 2017 · External reference

Schistosomiasis messaging in endemic communities: Lessons and implications for interventions from rural Uganda, a rapid ethnographic assessment study

10.1371/journal.pntd.0009893 · 2021 · External reference

Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda

10.1016/s0035-9203(03)80044-5 · 2003 · External reference

Control and Elimination of Schistosomiasis as a Public Health Problem: Thresholds Fail to Differentiate Schistosomiasis Morbidity Prevalence in Children

10.1093/ofid/ofab179 · 2021 · External reference

Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment

2014 · External reference

Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren

10.2471/blt.06.030353 · 2007 · External reference

The short-term impact of Schistosoma mansoni infection on health-related quality of life: implications for current elimination policies

2024 · External reference

Unresolved reference

2021 · External reference

Welcome to the Tidyverse

10.21105/joss.01686 · 2019 · External reference

Unresolved reference

2021 · External reference

runjags: AnRPackage Providing Interface Utilities, Model Templates, Parallel Computing Methods and Additional Distributions for MCMC Models inJAGS

10.18637/jss.v071.i09 · 2016 · External reference

glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling

10.32614/rj-2017-066 · 2017 · External reference

Dose-Response Analysis Using R

10.1371/journal.pone.0146021 · 2015 · External reference

A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables

10.1037/1082-989x.11.1.54 · 2006 · External reference

Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni

10.4269/ajtmh.1995.53.167 · 1995 · External reference

Defining elimination as a public health problem for schistosomiasis control programmes: beyond prevalence of heavy-intensity infections

10.1016/s2214-109x(22)00287-x · 2022 · External reference

Soil-transmitted helminth infections

10.1016/s0140-6736(17)31930-x · 2018 · External reference

Unresolved reference

External reference

Unresolved reference

2023 · External reference

Morbidity due to Schistosoma mansoni: an epidemiological assessment of distended abdomen syndrome in Ugandan school children with observations before and 1-year after anthelminthic chemotherapy

10.1016/j.trstmh.2005.12.013 · 2006 · External reference

Water quality and health conditions in Lake Victoria region, Uganda

2005 · External reference

Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda

10.1016/j.trstmh.2005.03.015 · 2006 · External reference

10.1101/2021.03.09.434291

10.1101/2021.03.09.434291 · External reference